Technology Platform

Adenovirus-based viral vector vaccine technology

 

2-141110110R5127.png

 

This technology enabled us to translate our globally innovative Ebola virus vaccine from a concept to an approved product in only three years. Our adenovirus-based vector technology is also applied to our TB Booster and other vaccine candidates.